查看購物車
  • English
封面
市場調查報告書
商品編碼
1914593

生醫冷藏庫和冷凍庫市場－全球產業規模、佔有率、趨勢、機會及預測（按產品、儲存方式、溫度、容量、最終用戶、地區和競爭格局分類），2021-2031年

Biomedical Refrigerators and Freezers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast Segmented By Product, By Storage, By Temperature, By Capacity, By End-user, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球生物醫學冷藏庫和冷凍庫市場預計將從2025年的44.2億美元成長到2031年的62.5億美元，複合年成長率（CAGR）為5.94%。這些專業的低溫儲存系統旨在將藥物化合物、疫苗、血液製品和樣本的生物穩定性維持在穩定且精確的溫度下。市場成長的主要促進因素是全球慢性病發病率的上升，這些疾病需要廣泛應用血漿療法，以及基因組研究和生物銀行建設的快速發展。此外，對溫度敏感的mRNA疫苗和生物製藥日益成長的配送需求，也加速了整個醫療網路對可靠的醫用級低溫運輸基礎設施的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 44.2億美元
市場規模：2031年 62.5億美元
複合年成長率：2026-2031年 5.94%
成長最快的細分市場 超低溫冷凍庫
最大的市場 北美洲

儘管市場前景廣闊，但仍面臨許多挑戰：超低溫儲存設備營運和資本成本高昂，會對設施預算造成巨大壓力，尤其是在資源匱乏的地區。保護高價值醫療資產免於損失仍是重中之重。國際航空運輸協會 (IATA) 的報告強調了可靠溫控的重要性，報告指出，到 2024 年，全球醫藥行業的貨物運輸量將超過 1 兆美元，這表明可靠的儲存解決方案在保護這些昂貴且敏感的產品方面發揮著至關重要的作用。

市場促進因素

疫苗儲存和分發需求的激增是全球低溫運輸基礎設施重建的主要驅動力。公共衛生機構正優先推進免疫供應鏈的現代化，尤其要確保溫度敏感型疫苗（例如基於mRNA的保護劑）的有效性，並加快採購能夠維持全球精準溫度條件的醫用冷藏庫。聯合國兒童基金會於2024年4月發布的《2023年度供應報告》顯示，約有28億劑疫苗已交付至105個國家，凸顯了這項物流挑戰的規模之大。同時，製藥業也投入了大量資金。例如，Astra Zeneca於2024年2月發布的《2023年度供應報告》顯示，該公司已在研發方面投資109億美元，凸顯了其在研產品價值高昂，需要可靠的儲存設施。

同時，節能環保製冷設備的採用正日益影響採購決策。醫療機構面臨著降低營運成本和減少碳排放的壓力，這促使它們從傳統的氫氟碳化合物（HFC）冷凍設備轉向永續的替代方案。製造商正透過開發符合環保認證且不犧牲熱穩定性的先進系統來滿足這項需求。根據賽默飛世爾科技公司於2024年5月發布的《2023年企業社會責任報告》，該公司最新的天然冷媒超低溫冷凍庫比以往型號節能高達38%，吸引了那些希望在嚴格的儲存標準和永續性目標之間取得平衡的設施管理人員的注意。

市場挑戰

醫用低溫儲存和超低溫設備的高購買成本和營運成本嚴重限制了全球生物醫學冷藏庫和冷凍庫市場的擴張。這些複雜的設備需要大量的初始投資，給小規模​​的實驗室和醫療機構，尤其是在資源匱乏的地區，造成了巨大的經濟負擔。這種經濟負擔不僅限於初始購買成本；維持精確溫度所需的大量能源消耗也會產生持續的營運成本，這進一步加重了醫療機構的預算壓力。

這種經濟壓力迫使各機構限制生物銀行和藥品儲存能力，並推遲老舊基礎設施的更新換代，直接阻礙了市場成長。近期產業數據顯示，低溫運輸營運和維護成本的上升趨勢也印證了這一點。根據全球低溫運輸聯盟（GCC）發布的《2024年報告》，今年第一季冷庫營運費用較去年同期成長了6.47%。不斷上漲的營運成本迫使採購部門凍結資本支出，導致新訂單量下降，進而阻礙了整體市場發展。

市場趨勢

物聯網賦能的遠端監控系統整合正在變革市場。這些智慧型設備透過即時數據傳輸提升樣本安全性，利用先進的感測器追蹤濕度和溫度，使機構能夠立即識別可能危及資產的偏差。這種互聯互通對於維持疫苗接種計劃中的低溫運輸以及在物理監控受限的偏遠地區進行分散式臨床試驗至關重要。海爾生物醫學2024年11月發表的報導《海爾生物醫藥的智慧疫苗解決方案：守護全球健康》印證了這項技術的廣泛應用。文章指出，海爾生物醫藥的整合式智慧疫苗解決方案已在80多個國家和地區部署，協助安全接種疫苗。

同時，RFID技術作為一種減少人為錯誤的手段正日益受到關注。與條碼不同，配備RFID功能的冷藏庫可以即時、非接觸式地識別樣本，並減少管瓶在審核中暴露於環境溫度的時間。這種自動化簡化了工作流程，並確保了符合監管要求的數位化審核追蹤。醫療機構正在優先推動數位化，以保護高價值庫存。根據斑馬技術公司於2024年5月發布的《醫院願景調查》，約68%的醫院管理者計劃在未來五年內實施RFID解決方案，以提高庫存可視性。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球生物醫學冷藏庫與冷凍庫市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（直通式、防爆式、易燃物儲存式、組合/雙溫式、超低溫冷凍庫、等離子冷凍庫、其他）
    • 依儲存物品類型（血液、疫苗、血漿、DNA、易燃化學品、其他）
    • 依溫度分類（RNA/DNA（-70 度C至 -80 度C），疫苗（-30 度C至 -40 度C），其他）
    • 按容量（138公升、169公升、221公升、230公升、426公升、690公升及其他）
    • 依最終使用者（醫院、藥局、診斷中心、實驗室、血庫）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美生物醫學冷藏庫和冷凍庫市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲生物醫學冷藏庫和冷凍庫市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區生物醫學冷藏庫與冷凍庫市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲生物醫學冷藏庫和冷凍庫市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章 南美洲生物醫學冷藏庫和冷凍庫市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球生物醫學冷藏庫與冷凍庫市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Thermo Fisher Scientific Inc.
  • Terumo BCT, Inc.
  • Eppendorf AG
  • PHC Corporation
  • Haier Inc.
  • Arctiko A/S
  • Binder GmbH
  • Bionics Scientific Technologies Inc.
  • Desmon SpA
  • Froilabo-Techcomp Group

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 4537

The Global Biomedical Refrigerators and Freezers market is projected to expand from USD 4.42 billion in 2025 to USD 6.25 billion by 2031, registering a CAGR of 5.94%. These specialized cold storage systems are designed to maintain the biological stability of pharmaceutical compounds, vaccines, blood products, and samples at constant, precise temperatures. Market growth is primarily fueled by the increasing global incidence of chronic diseases requiring extensive plasma therapies, alongside the rapid development of genomic research and biobanking efforts. Furthermore, the growing need to distribute temperature-sensitive mRNA vaccines and biologic drugs has heightened the demand for reliable medical-grade cold chain infrastructure throughout healthcare networks.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.42 Billion
Market Size 2031USD 6.25 Billion
CAGR 2026-20315.94%
Fastest Growing SegmentUltra Low freezers
Largest MarketNorth America

Despite these growth prospects, the market faces a substantial obstacle in the form of high operational and capital costs linked to ultra-low temperature units, which can burden facility budgets, especially in resource-constrained areas. Safeguarding high-value medical assets remains a top priority to prevent loss. Highlighting the importance of reliable temperature control, the International Air Transport Association reported in 2024 that the pharmaceutical sector transported over one trillion dollars in cargo worldwide, demonstrating the essential role of dependable preservation solutions in protecting these sensitive and expensive products.

Market Driver

The surging demand for vaccine storage and distribution serves as a major catalyst for reshaping global cold chain infrastructure. Public health organizations are prioritizing the modernization of immunization supply chains to guarantee the efficacy of temperature-sensitive formulations, especially mRNA-based protectants, driving the procurement of medical-grade refrigerators that can maintain precise conditions worldwide. Illustrating the scale of this logistical challenge, UNICEF's "Supply Annual Report 2023," published in April 2024, noted the delivery of nearly 2.8 billion vaccine doses to 105 countries. This volume corresponds with significant capital investments in the pharmaceutical sector; for instance, AstraZeneca's "Annual Report 2023" from February 2024 revealed a $10.9 billion investment in R&D, underscoring the high value of pipeline assets needing reliable preservation.

Simultaneously, purchasing decisions are increasingly influenced by the adoption of energy-efficient and eco-friendly refrigeration models. Healthcare facilities are under growing pressure to lower utility costs and reduce their carbon footprint, prompting a transition from traditional hydrofluorocarbon-based units to sustainable alternatives. Manufacturers are meeting this demand by engineering advanced systems that comply with environmental certifications without sacrificing thermal stability. According to Thermo Fisher Scientific's "2023 Corporate Social Responsibility Report" released in May 2024, their latest ultra-low temperature freezers using natural refrigerants consume up to 38% less energy than previous models, attracting facility managers who seek to balance institutional sustainability goals with rigorous storage standards.

Market Challenge

The expansion of the Global Biomedical Refrigerators and Freezers market is significantly hindered by the high capital and operational costs associated with medical-grade cold storage and ultra-low temperature units. These complex devices necessitate substantial upfront investment, creating a severe financial barrier for smaller research laboratories and healthcare facilities, particularly in regions with limited resources. The financial strain extends beyond the initial purchase, as the significant energy consumption required to maintain precise temperatures leads to continuous overhead expenses that further deplete facility budgets.

This economic pressure directly impedes market growth by compelling organizations to limit their biobanking and pharmaceutical storage capabilities or delay the replacement of aging infrastructure. The rising cost of maintaining cold chain operations is supported by recent industry data; the Global Cold Chain Alliance reported in 2024 that expenses for operating refrigerated facilities increased by 6.47 percent in the first quarter compared to the same period the previous year. Such escalating operational costs force procurement departments to freeze capital expenditures, thereby reducing the volume of new orders and stifling the overall development of the market.

Market Trends

The market is being transformed by the integration of IoT-enabled remote monitoring systems, which enhance sample safety through real-time data transmission. These smart units employ advanced sensors to track humidity and temperature, allowing facilities to instantly identify deviations that could jeopardize assets. This connectivity is essential for maintaining the cold chain in remote vaccination programs and decentralized trials where physical oversight is limited. The extent of this adoption is illustrated by Haier Biomedical's November 2024 article, "HB's Smart Vaccine Solution: Safeguarding Global Health," which notes that their integrated smart vaccine solution has been deployed in over 80 countries and regions to ensure safe immunization delivery.

Concurrently, RFID technology is gaining traction as a means to minimize manual handling errors. Unlike barcodes, RFID-enabled refrigerators facilitate the instantaneous, touchless identification of samples, reducing the time vials are exposed to ambient temperatures during audits. This automation streamlines workflows and secures a digital audit trail for regulatory compliance. Healthcare institutions are prioritizing this digitalization to protect high-value inventory; according to Zebra Technologies' "Hospital Vision Study" from May 2024, nearly 68 percent of hospital leaders plan to implement RFID solutions within the next five years to enhance inventory visibility.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • Terumo BCT, Inc.
  • Eppendorf AG
  • PHC Corporation
  • Haier Inc.
  • Arctiko A/S
  • Binder GmbH
  • Bionics Scientific Technologies Inc.
  • Desmon S.p.A.
  • Froilabo - Techcomp Group

Report Scope

In this report, the Global Biomedical Refrigerators and Freezers market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biomedical Refrigerators and Freezers market, By Product

  • Pass-Through
  • Explosion Safe
  • Flammable storage
  • Combo/Dual Temperature
  • Ultra Low freezers
  • Plasma freezers
  • Others

Biomedical Refrigerators and Freezers market, By Storage

  • Blood
  • Vaccines
  • Plasma
  • DNA
  • Flammable chemicals
  • Others

Biomedical Refrigerators and Freezers market, By Temperature

  • RNA & DNA (-70°C to -80°C)
  • Vaccines (-30°C to -40 °C)
  • Others

Biomedical Refrigerators and Freezers market, By Capacity

  • 138L
  • 169L
  • 221L
  • 230L
  • 426L
  • 690L
  • Others

Biomedical Refrigerators and Freezers market, By End-user

  • Hospitals
  • Pharmacies
  • Diagnostic Centers
  • Research Laboratories
  • Blood Banks

Biomedical Refrigerators and Freezers market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biomedical Refrigerators and Freezers market.

Available Customizations:

Global Biomedical Refrigerators and Freezers market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biomedical Refrigerators and Freezers market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Pass-Through, Explosion Safe, Flammable storage, Combo/Dual Temperature, Ultra Low freezers, Plasma freezers, Others)
    • 5.2.2. By Storage (Blood, Vaccines, Plasma, DNA, Flammable chemicals, Others)
    • 5.2.3. By Temperature (RNA & DNA (-70°C to -80°C), Vaccines (-30°C to -40 °C), Others)
    • 5.2.4. By Capacity (138L, 169L, 221L, 230L, 426L, 690L, Others)
    • 5.2.5. By End-user (Hospitals, Pharmacies, Diagnostic Centers, Research Laboratories, Blood Banks)
    • 5.2.6. By Region
    • 5.2.7. By Company (2025)
  • 5.3. Market Map

6. North America Biomedical Refrigerators and Freezers market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Storage
    • 6.2.3. By Temperature
    • 6.2.4. By Capacity
    • 6.2.5. By End-user
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biomedical Refrigerators and Freezers market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Storage
        • 6.3.1.2.3. By Temperature
        • 6.3.1.2.4. By Capacity
        • 6.3.1.2.5. By End-user
    • 6.3.2. Canada Biomedical Refrigerators and Freezers market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Storage
        • 6.3.2.2.3. By Temperature
        • 6.3.2.2.4. By Capacity
        • 6.3.2.2.5. By End-user
    • 6.3.3. Mexico Biomedical Refrigerators and Freezers market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Storage
        • 6.3.3.2.3. By Temperature
        • 6.3.3.2.4. By Capacity
        • 6.3.3.2.5. By End-user

7. Europe Biomedical Refrigerators and Freezers market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Storage
    • 7.2.3. By Temperature
    • 7.2.4. By Capacity
    • 7.2.5. By End-user
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Biomedical Refrigerators and Freezers market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Storage
        • 7.3.1.2.3. By Temperature
        • 7.3.1.2.4. By Capacity
        • 7.3.1.2.5. By End-user
    • 7.3.2. France Biomedical Refrigerators and Freezers market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Storage
        • 7.3.2.2.3. By Temperature
        • 7.3.2.2.4. By Capacity
        • 7.3.2.2.5. By End-user
    • 7.3.3. United Kingdom Biomedical Refrigerators and Freezers market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Storage
        • 7.3.3.2.3. By Temperature
        • 7.3.3.2.4. By Capacity
        • 7.3.3.2.5. By End-user
    • 7.3.4. Italy Biomedical Refrigerators and Freezers market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Storage
        • 7.3.4.2.3. By Temperature
        • 7.3.4.2.4. By Capacity
        • 7.3.4.2.5. By End-user
    • 7.3.5. Spain Biomedical Refrigerators and Freezers market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Storage
        • 7.3.5.2.3. By Temperature
        • 7.3.5.2.4. By Capacity
        • 7.3.5.2.5. By End-user

8. Asia Pacific Biomedical Refrigerators and Freezers market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Storage
    • 8.2.3. By Temperature
    • 8.2.4. By Capacity
    • 8.2.5. By End-user
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Biomedical Refrigerators and Freezers market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Storage
        • 8.3.1.2.3. By Temperature
        • 8.3.1.2.4. By Capacity
        • 8.3.1.2.5. By End-user
    • 8.3.2. India Biomedical Refrigerators and Freezers market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Storage
        • 8.3.2.2.3. By Temperature
        • 8.3.2.2.4. By Capacity
        • 8.3.2.2.5. By End-user
    • 8.3.3. Japan Biomedical Refrigerators and Freezers market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Storage
        • 8.3.3.2.3. By Temperature
        • 8.3.3.2.4. By Capacity
        • 8.3.3.2.5. By End-user
    • 8.3.4. South Korea Biomedical Refrigerators and Freezers market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Storage
        • 8.3.4.2.3. By Temperature
        • 8.3.4.2.4. By Capacity
        • 8.3.4.2.5. By End-user
    • 8.3.5. Australia Biomedical Refrigerators and Freezers market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Storage
        • 8.3.5.2.3. By Temperature
        • 8.3.5.2.4. By Capacity
        • 8.3.5.2.5. By End-user

9. Middle East & Africa Biomedical Refrigerators and Freezers market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Storage
    • 9.2.3. By Temperature
    • 9.2.4. By Capacity
    • 9.2.5. By End-user
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Biomedical Refrigerators and Freezers market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Storage
        • 9.3.1.2.3. By Temperature
        • 9.3.1.2.4. By Capacity
        • 9.3.1.2.5. By End-user
    • 9.3.2. UAE Biomedical Refrigerators and Freezers market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Storage
        • 9.3.2.2.3. By Temperature
        • 9.3.2.2.4. By Capacity
        • 9.3.2.2.5. By End-user
    • 9.3.3. South Africa Biomedical Refrigerators and Freezers market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Storage
        • 9.3.3.2.3. By Temperature
        • 9.3.3.2.4. By Capacity
        • 9.3.3.2.5. By End-user

10. South America Biomedical Refrigerators and Freezers market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Storage
    • 10.2.3. By Temperature
    • 10.2.4. By Capacity
    • 10.2.5. By End-user
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Biomedical Refrigerators and Freezers market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Storage
        • 10.3.1.2.3. By Temperature
        • 10.3.1.2.4. By Capacity
        • 10.3.1.2.5. By End-user
    • 10.3.2. Colombia Biomedical Refrigerators and Freezers market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Storage
        • 10.3.2.2.3. By Temperature
        • 10.3.2.2.4. By Capacity
        • 10.3.2.2.5. By End-user
    • 10.3.3. Argentina Biomedical Refrigerators and Freezers market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Storage
        • 10.3.3.2.3. By Temperature
        • 10.3.3.2.4. By Capacity
        • 10.3.3.2.5. By End-user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Biomedical Refrigerators and Freezers market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Terumo BCT, Inc.
  • 15.3. Eppendorf AG
  • 15.4. PHC Corporation
  • 15.5. Haier Inc.
  • 15.6. Arctiko A/S
  • 15.7. Binder GmbH
  • 15.8. Bionics Scientific Technologies Inc.
  • 15.9. Desmon S.p.A.
  • 15.10. Froilabo - Techcomp Group

16. Strategic Recommendations

17. About Us & Disclaimer